Mark Stoopler
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Cancer Diagnosis and Treatment
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Metastasis and carcinoma case studies
Papers in
-
- Lung Cancer Treatments and Mutations 8
- Lung Cancer Diagnosis and Treatment 3
- Oncology 7
- Lung Cancer Research Studies 3
- Cancer Immunotherapy and Biomarkers 3
- Cancer Treatment and Pharmacology 1
- Vascular Tumors and Angiosarcomas 1
- Co-authors
- Joshua Sonett (6 shared papers)Catherine A. Shu (6 shared papers)Anjali Saqi (6 shared papers)Naiyer A. Rizvi (5 shared papers)Alain Borczuk (3 shared papers)Simon K. Cheng (3 shared papers)Balázs Halmos (3 shared papers)Mark M. Awad (2 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)Cancer (1 paper)Journal of Clinical Medicine (1 paper)American Journal of Clinical Nutrition (1 paper)Urology (1 paper)
- Partner nations
- United StatesTaiwan
In The Last Decade
Mark Stoopler
17 papers receiving 1.1k citations
Mark Stoopler's Hit Papers
Peers
Comparison fields: 5 of 63
- Oncology 725
- Pulmonary and Respiratory Medicine 852
- Cancer Research 162
- Hepatology 55
- Surgery 159
Countries citing papers authored by Mark Stoopler
This map shows the geographic impact of Mark Stoopler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Stoopler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Stoopler more than expected).
Fields of papers citing papers by Mark Stoopler
This network shows the impact of papers produced by Mark Stoopler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Stoopler. The network helps show where Mark Stoopler may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Stoopler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial Hit paper breakdown → | 2020 | 425 |
| 2 | 2015 | 242 | |
| 3 | 2017 | 158 | |
| 4 | 2010 | 63 | |
| 5 | 2019 | 50 | |
| 6 | 2003 | 38 | |
| 7 | 2015 | 37 | |
| 8 | 2018 | 31 | |
| 9 | 1993 | 23 | |
| 10 | 1974 | 17 | |
| 11 | Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer. | 1982 | 17 |
| 12 | 2020 | 14 | |
| 13 | 2016 | 12 | |
| 14 | 1989 | 11 | |
| 15 | 2020 | 7 | |
| 16 | 1975 | 6 | |
| 17 | Systemic sclerosis and regional enteritis occurring simultaneously. | 1976 | 3 |
About Mark Stoopler
Mark Stoopler is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology and Epidemiology, having authored 17 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cancer Genomics and Diagnostics (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Neuroendocrine Tumor Research Advances (2 papers), Cancer Treatment and Pharmacology (1 paper) and Vascular Tumors and Angiosarcomas (1 paper). The work is most often cited by research in Oncology (725 citations), Pulmonary and Respiratory Medicine (852 citations), Cancer Research (162 citations), Hepatology (55 citations) and Surgery (159 citations). Mark Stoopler has collaborated with scholars based in United States and Taiwan. Frequent co-authors include Joshua Sonett, Catherine A. Shu, Anjali Saqi, Naiyer A. Rizvi, Alain Borczuk, Simon K. Cheng, Balázs Halmos, Mark M. Awad, F. D’Ovidio and Codruța Chiuzan. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Journal of Clinical Medicine, American Journal of Clinical Nutrition and Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.